The Shape of Innovation // Ep. 4: Innovation in biotech – through recombination, not just invention
|
|
The shape of business innovation has changed radically over the past 30 years. This podcast series explores the changing shape of innovation through conversations with real-world innovation practitioners and leaders.
In this 20’04” episode Principal Analyst Angela Ashenden talks to innovation leader Frank Hatzack about his experience driving innovation at biotech firm Novozymes, and his own approach and perspectives on innovation.
Topics covered in this episode:
- How Frank shifted from an R&D role into new business creation through innovation
- The different approaches to innovation at Novozymes, and the importance of recombining existing assets and resources to create new opportunities
- How Novozymes embraced crowdsourcing across its value chain to scale its innovation efforts
- The risks of creating incubators that attract your best people away from your core business
- … and much more!
Frank is now a Senior Consultant for www.rInnovationgroup.com. You can email him on frank dot hatzack at rinnovationgroup dot com; on Twitter he’s @frankhatzack.
Please let us know what you think in comments below, or feel free to contact editor@mwdadvisors.com if you have questions or comments – or if you’d like to get involved in a future conversation!
The post The Shape of Innovation // Ep. 4: Innovation in biotech – through recombination, not just invention appeared first on The Advisor.